A Study to Evaluate Bioavailability and Food Effect of Selumetinib (AZD6244) in Healthy Male participants

Trial Identifier:	D1532C00089
Sponsor:	AstraZeneca
NCTID::	NCT03649165
Start Date:	September 2018
Primary Completion Date:	October 2018
Study Completion Date:	October 2018

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States of America, MD	Baltimore, MD, United States of America, 21225

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.